11-46875564-G-T

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_002334.4(LRP4):​c.3817C>A​(p.Arg1273Arg) variant causes a synonymous change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00297 in 1,614,078 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 22 hom. )

Consequence

LRP4
NM_002334.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 8.13

Publications

3 publications found
Variant links:
Genes affected
LRP4 (HGNC:6696): (LDL receptor related protein 4) This gene encodes a member of the low-density lipoprotein receptor-related protein family. The encoded protein may be a regulator of Wnt signaling. Mutations in this gene are associated with Cenani-Lenz syndrome. [provided by RefSeq, May 2010]
LRP4 Gene-Disease associations (from GenCC):
  • Cenani-Lenz syndactyly syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • congenital myasthenic syndrome 17
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sclerosteosis 2
    Inheritance: SD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 11-46875564-G-T is Benign according to our data. Variant chr11-46875564-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211405.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0036 (548/152206) while in subpopulation NFE AF = 0.00503 (342/68008). AF 95% confidence interval is 0.00459. There are 1 homozygotes in GnomAd4. There are 321 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 22 AR,SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP4NM_002334.4 linkc.3817C>A p.Arg1273Arg synonymous_variant Exon 27 of 38 ENST00000378623.6 NP_002325.2
LRP4XM_017017734.2 linkc.3817C>A p.Arg1273Arg synonymous_variant Exon 27 of 39 XP_016873223.1
LRP4XM_011520103.3 linkc.3013C>A p.Arg1005Arg synonymous_variant Exon 21 of 32 XP_011518405.1
LRP4XM_011520104.3 linkc.1582C>A p.Arg528Arg synonymous_variant Exon 12 of 23 XP_011518406.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP4ENST00000378623.6 linkc.3817C>A p.Arg1273Arg synonymous_variant Exon 27 of 38 1 NM_002334.4 ENSP00000367888.1

Frequencies

GnomAD3 genomes
AF:
0.00360
AC:
548
AN:
152088
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000830
Gnomad FIN
AF:
0.0160
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.00503
Gnomad OTH
AF:
0.00288
GnomAD2 exomes
AF:
0.00403
AC:
1012
AN:
251250
AF XY:
0.00415
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000983
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0138
Gnomad NFE exome
AF:
0.00553
Gnomad OTH exome
AF:
0.00440
GnomAD4 exome
AF:
0.00291
AC:
4251
AN:
1461872
Hom.:
22
Cov.:
35
AF XY:
0.00301
AC XY:
2188
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33480
American (AMR)
AF:
0.000894
AC:
40
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
11
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000591
AC:
51
AN:
86258
European-Finnish (FIN)
AF:
0.0130
AC:
694
AN:
53412
Middle Eastern (MID)
AF:
0.00485
AC:
28
AN:
5768
European-Non Finnish (NFE)
AF:
0.00292
AC:
3246
AN:
1111998
Other (OTH)
AF:
0.00286
AC:
173
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
289
577
866
1154
1443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00360
AC:
548
AN:
152206
Hom.:
1
Cov.:
32
AF XY:
0.00431
AC XY:
321
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41536
American (AMR)
AF:
0.000719
AC:
11
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.000831
AC:
4
AN:
4814
European-Finnish (FIN)
AF:
0.0160
AC:
170
AN:
10610
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.00503
AC:
342
AN:
68008
Other (OTH)
AF:
0.00285
AC:
6
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00427
Hom.:
4
Bravo
AF:
0.00214
EpiCase
AF:
0.00376
EpiControl
AF:
0.00362

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LRP4: BP4, BS2

Sep 01, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cenani-Lenz syndactyly syndrome Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

not specified Benign:1
Feb 13, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cenani-Lenz syndactyly syndrome;C3280402:Sclerosteosis 2;C4225377:Congenital myasthenic syndrome 17 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
8.0
DANN
Benign
0.79
PhyloP100
8.1
Mutation Taster
=29/71
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61746928; hg19: chr11-46897115; API